Cardiac arrest & resuscitation

Naloxone administration associated with improved survival in PEA out-of-hospital cardiac arrests

ResuscitationPublished Retrospective cohort study

Authors' conclusion

In this national cohort, naloxone administration was associated with improved survival to hospital discharge for OHCA patients in PEA. No association was found between naloxone and clinical outcomes for OHCA patients with shockable rhythms or asystole.

Study context

Population
OHCA patients, US ESO Data Collaborative 2019–2020, classified a priori by presenting rhythm (shockable, PEA, asystole)cases analysed
Participants
40,333 patients
Exposure
Prehospital naloxone vs no naloxone, stratified by presenting rhythm
  • Naloxonen = 7,567
Outcome
Prehospital ROSC and survival to hospital discharge, stratified by presenting rhythm
Methodological detailspropensity-score matched, national registry (ESO Data Collaborative), Retrospective design: selection bias and resuscitation time bias not fully addressed; causality cannot be inferred
  • Propensity-score matched
  • National registry (ESO Data Collaborative)
  • Retrospective design: selection bias and resuscitation time bias not fully addressed; causality cannot be inferred

Main finding

As reported in the abstract

Survival to hospital discharge and prehospital ROSC, PEA (after propensity-score matching)
Naloxone vs No naloxoneEstimate (95% CI)
PEA
OR for survival to hospital discharge 1.46(1.11–1.92)
PEA; similar rates
OR for prehospital ROSC 1.09(0.90–1.31)

Observational data: associations, not effects.

Further findings

Overall outcomes before matching (all cases)

Prehospital ROSC
21.5%
Survival to hospital discharge
9.0%

Original publication

Naloxone administration associated with improved survival in PEA out-of-hospital cardiac arrests. Resuscitation. Published 22 May 2026. doi:10.1016/j.resuscitation.2026.111139

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.